首页> 外文期刊>American Journal of Kidney Diseases: The official journal of the National Kidney Foundation >Effect of fluid management guided by bioimpedance spectroscopy on cardiovascular parameters in hemodialysis patients: A randomized controlled trial
【24h】

Effect of fluid management guided by bioimpedance spectroscopy on cardiovascular parameters in hemodialysis patients: A randomized controlled trial

机译:生物阻抗谱指导的液体管理对血液透析患者心血管参数的影响:一项随机对照试验

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Fluid overload is the main determinant of hypertension and left ventricular hypertrophy in hemodialysis patients. However, assessment of fluid overload can be difficult in clinical practice. We investigated whether objective measurement of fluid overload with bioimpedance spectroscopy is helpful in optimizing fluid status. Study Design: Prospective, randomized, and controlled study. Setting & Participants: 156 hemodialysis patients from 2 centers were randomly assigned to 2 groups. Intervention: Dry weight was assessed by routine clinical practice and fluid overload was assessed by bioimpedance spectroscopy in both groups. In the intervention group (n = 78), fluid overload information was provided to treating physicians and used to adjust fluid removal during dialysis. In the control group (n = 78), fluid overload information was not provided to treating physicians and fluid removal during dialysis was adjusted according to usual clinical practice. Outcomes: The primary outcome was regression of left ventricular mass index during a 1-year follow-up. Improvement in blood pressure and left atrial volume were the main secondary outcomes. Changes in arterial stiffness parameters were additional outcomes. Measurements: Fluid overload was assessed twice monthly in the intervention group and every 3 months in the control group before the mid- or end-week hemodialysis session. Echocardiography, 48-hour ambulatory blood pressure measurement, and pulse wave analysis were performed at baseline and 12 months. Results: Baseline fluid overload parameters in the intervention and control groups were 1.45 ± 1.11 (SD) and 1.44 ± 1.12 L, respectively (P = 0.7). Time-averaged fluid overload values significantly decreased in the intervention group (mean difference, -0.5 ± 0.8 L), but not in the control group (mean difference, 0.1 ± 1.2 L), and the mean difference between groups was -0.5 L (95% CI, -0.8 to -0.2; P = 0.001). Left ventricular mass index regressed from 131 ± 36 to 116 ± 29 g/m2 (P 0.001) in the intervention group, but not in the control group (121 ± 35 to 120 ± 30 g/m2; P = 0.9); mean difference between groups was -10.2 g/m2 (95% CI, -19.2 to -1.17 g/m2; P = 0.04). In addition, values for left atrial volume index, blood pressure, and arterial stiffness parameters decreased in the intervention group, but not in the control group. Limitations: Ambulatory blood pressure data were not available for all patients. Conclusions: Assessment of fluid overload with bioimpedance spectroscopy provides better management of fluid status, leading to regression of left ventricular mass index, decrease in blood pressure, and improvement in arterial stiffness.
机译:背景:液体超负荷是血液透析患者高血压和左心室肥大的主要决定因素。但是,在临床实践中很难评估体液超负荷。我们调查了使用生物阻抗光谱法客观测量流体过载是否有助于优化流体状态。研究设计:前瞻性,随机和对照研究。参加者:2个中心的156名血液透析患者被随机分为2组。干预:两组均通过常规临床实践评估干重,并通过生物阻抗光谱法评估体液超负荷。在干预组(n = 78)中,向医生提供了液体超负荷信息,并用于调整透析期间的液体去除。在对照组(n = 78)中,没有向主治医生提供液体超负荷信息,并且根据常规临床实践对透析期间的液体去除进行了调整。结果:主要结果是在1年的随访期间左心室质量指数下降。血压和左房容量的改善是主要的次要结局。动脉僵硬度参数的变化是其他结果。测量:干预组每月两次评估液体超负荷,而在周中或末日进行血液透析之前,对照组每3个月评估一次。在基线和12个月时进行超声心动图检查,48小时动态血压测量和脉搏波分析。结果:干预组和对照组的基线液体超负荷参数分别为1.45±1.11(SD)和1.44±1.12 L(P = 0.7)。干预组的时间平均体液超负荷值显着降低(平均差异为-0.5±0.8 L),而对照组则没有(平均差异为0.1±1.2 L),并且两组之间的平均差异为-0.5 L( 95%CI,-0.8至-0.2; P = 0.001)。干预组左心室质量指数从131±36降低至116±29 g / m2(P <0.001),而对照组则没有(121±35至120±30 g / m2; P = 0.9);两组之间的平均差异为-10.2 g / m2(95%CI,-19.2至-1.17 g / m2; P = 0.04)。此外,干预组的左心房容积指数,血压和动脉僵硬度参数值均降低,而对照组则没有。局限性:并非所有患者都有动态血压数据。结论:利用生物阻抗光谱法评估体液超负荷可更好地管理体液状态,导致左心室质量指数下降,血压降低和动脉僵硬度改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号